Study Will Explore Early Detection of Atrial Fibrillation to Reduce Stroke and Heart Failure Risk Through Home Blood Pressure ...
GlobalData on MSN
Actinogen treats first patient in XanaMIA trial for Alzheimer’s
Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.
Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
An artificial intelligence (AI) virtual assistant designed to help patients suffering from heart failure with reduced ejection fraction ...
Clinical Trials Arena on MSN
AstraZeneca reports positive data from phase III trial of efzimfotase alfa
The programme enrolled 196 children, adolescents, and adults with either paediatric-onset or adult-onset HPP.
Morning Overview on MSN
Study links weight training to slower brain aging in older adults
A large brain imaging trial suggests that regular weight training may slow how quickly the brain appears to age in older ...
Phase III randomized placebo-controlled trial on repurposing olanzapine for prevention of radiotherapy-induced nausea and vomiting (RINV): CTRI/2022/01/039723. PNQ ≥D 3 months after end of PTX 32.0% ...
LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this ...
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...
Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results